EM-T3Expert Opinion on Drug Safety2025-01-30第 25 卷第 7 期，1351-1359高影响力 · 前 10%
Liver injury related to vascular endothelial growth factor tyrosine kinase inhibitors: a pharmacovigilance analysis of the USA FDA adverse event reporting system (FAERS) database
